UroGen Pharma Ltd. (LON:0XOD)
18.80
+0.30 (1.60%)
At close: Sep 5, 2025
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of 731.77 million as of September 9, 2025. Its market cap has increased by 52.71% in one year.
Market Cap
731.77M
Enterprise Value
706.57M
Revenue
68.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.80
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from 129.71M to 731.77M, an increase of 464.17%. That is a compound annual growth rate of 23.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 8, 2025 | 731.77M | 103.84% |
Dec 31, 2024 | 358.99M | -1.24% |
Dec 29, 2023 | 363.49M | 113.84% |
Dec 30, 2022 | 169.98M | 7.95% |
Dec 31, 2021 | 157.47M | -46.00% |
Dec 31, 2020 | 291.60M | -44.84% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
May 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 187.48B |
HSBC Holdings | 166.28B |
Shell | 153.39B |
Unilever | 118.73B |
Rolls-Royce Holdings | 90.34B |
British American Tobacco p.l.c. | 90.21B |
Rio Tinto Group | 79.80B |
BP p.l.c. | 64.23B |